How Modular Workflows Are Redefining CAR T Manufacturing

Learn how flexible modular workflows can help manufacturers improve process adaptability, throughput, and control while preserving key CAR T quality attributes, including transduction efficiency.

Rewriting The Code: Advances And Challenges In Pediatric Gene Therapy

This presentation examines pediatric gene therapy and the three platforms now driving clinical progress: AAV vectors, lentiviral vectors, and CRISPR-based gene editing.

The Hidden Cost of CRO Change Orders and How Sponsors Can Best Manage Them

Improve budget oversight, forecast costs more accurately, and maintain a clear audit trail to minimize surprises and streamline CRO change orders.

Navigating AI Compliance In Life Sciences: FDA Policy Insights For AI Governance

Navigating life sciences AI compliance requires strong governance, expert human oversight, and transparent, low-risk deployment strategies.

When High-Stakes ADC Decisions Can't Wait for More Material or Better Data

Learn how a material-sparing analytical workflow can generate reliable data, reduce dependence on calibration assays, and support faster, more confident candidate evaluation.

July Kincell Bio Webinar

Reducing Particulate-Related Batch Risk In Bioprocessing

Increasing scrutiny around particulate contamination is pushing teams to act earlier. Understanding where risks originate and applying proactive strategies can ease challenges across production.

A Closer Look At How Single Use Consumables Drive Cost Per Therapy

Single-use consumables can influence cost per therapy, validation risk, and scalability. Gain a practical perspective on spotting cost and risk signals early before they become barriers later.

Residual DNA Testing Across Biotherapeutics

Residual host cell DNA testing can create bottlenecks. Learn how digital PCR supports more consistent quantification, simpler method deployment, and faster in-process and lot release decisions.

Accelerating Clinical Data Review Without Losing Control

Faster clinical review requires more than automation. See how governed AI can help teams spot issues sooner and preserve trust, transparency, and expert control throughout decision-making.

Building Scalable Non-Viral Gene-Edited Cell Therapy Processes

Rahul Purohit, Ph.D., discusses the challenges and opportunities of scaling non-viral gene-edited cell therapies, with practical guidance for balancing performance, cell quality, and manufacturing readiness.

Global Regulatory Compliance For Aseptic Barrier Systems

Reconcile differing regulatory philosophies in sterile manufacturing. Learn to use prescriptive baselines and scientific data to achieve global compliance.

Automating cell therapy manufacturing without redesigning established workflow

Automating Cell Therapy Manufacturing Without Redesigning Workflows

Cell therapy manufacturing teams face mounting pressure to automate without disrupting workflows. Learn how incremental automation can preserve process integrity and reduce risk.

How Intensified Upstream Processing Improves Scale-Up And Tech Transfer

Intensified upstream processing can improve scalability and maintain quality. Learn how automation, PAT, and data-driven control strategies help modernize workflows and support consistent performance.

Smarter DNA, Healthier Cells

Standardizing cross-functional communication and unifying data architectures streamlines technology transfer, minimizes costly manufacturing deviations, and accelerates therapeutic scale-up.

Generate Stable High-Producing Clones In 14 Weeks

Rising complexity is putting pressure on cell line development. Discover a streamlined approach that enables rapid generation of stable clones with strong titers and long-term consistency.

Creative Chromatography Solutions For Complex Small Molecules

Chromatographic modeling enables smarter purification. Discover how digital tools, fraction mapping, and expert execution can improve yield for the most challenging small-molecule separations.

Using Residual DNA Quantification Data To De-Risk mAb Development

Residual DNA quantitation offers more than impurity measurement. When used across process steps, it helps compare purification performance, identify risks early, and ensure assays remain reliable.

The AI Advantage For Regulated Manufacturing

Transitioning from paper batch records to human-centered AI optimizes pharma manufacturing. Learn to secure data, cut review times by 90%, and build a strong Return on Automation business case.

Viral Safety Testing In Biologics: Detecting What Current Methods Miss

Biologics face unpredictable risks as complexity grows; evolving testing strategies to broaden detection, address gaps, and strengthen safety confidence without disrupting development or compliance.

From Gene Editing To NGS-Based T Cell Characterization

Gene-edited T cells targeting PD-1 and TIGIT are redefining approaches to cancer therapy. Explore how cell engineering and integrated genomic workflows uncover critical insights into T cell function.

Efficient mAb Development With A Flexible Purification Toolkit

Increasing mAb complexity is pushing purification beyond traditional platforms. See how flexible chromatography, optimized buffers, and adaptable workflows are becoming essential to achieve target purity.

How Solid-State Science Solves Your Toughest API Challenges

Difficult small molecules demand more than standard purification strategies. See how combining solid-state expertise with advanced chromatographic modeling improves filtration, purity, and scalability.

2026 Critical Manufacturing Trends Reshaping Pharma & Medical Device

Discover how modern life sciences manufacturers integrate digital threads and validated AI frameworks to eliminate operational silos, build supply chain resilience, and upskill the modern workforce.

Advancing Next Gen Antibodies: From AI Driven CLD To Manufacturing

See how growing ADC complexity is driving the adoption of AI-enabled, data-driven CMC strategies that accelerate development, improve product insight, and strengthen manufacturing readiness.

Challenges And Opportunities With Novel AAV Capsids

Explore challenges and solutions in developing novel AAV capsids, focusing on manufacturing complexity, analytical testing, and regulatory considerations for advancing gene therapy effectiveness.

From Complexity To Confidence: Supporting Tech Transfer With A Prefillable Syringe System

Discover how aligning packaging strategy with technology transfer requirements can accelerate timelines, control costs, and support successful injectable drug product manufacturing.

CAR-T Strategy In 2026: Scaling Autologous, Advancing Allogeneic

As CAR-T advances, shifting clinical progress and market dynamics are reshaping development strategies. Explore how evolving therapies and operational demands are redefining the next wave of innovation.

Quality By Design: The Future Of Automated Pharmaceutical Labeling

Learn how applying Quality by Design principles to automated labeling platforms utilizes robotics to eliminate manual errors and seamlessly adapt to future pharmaceutical packaging formats.